Interleukin-1 receptor antagonist reduces the magnitude of the pressor response to acute stress.
The purpose of the present study was to establish the effect of chronic central interleukin-1 receptors blockade and central chronic infusion of interleukin-1 beta (IL-1beta) on cardiovascular response to an acute stressor. The experiments were performed on 12-14-week-old, male WKY rats, divided into three experimental groups. Each group was subjected to chronic intracerebroventricular (ICV) infusion of one of the following compounds: saline (control, group C), recombinant rat IL-1 receptor antagonist (IL-ANT group) or interleukin-1 beta (IL-1B group). After 5 days of the ICV infusions mean arterial blood pressure (MABP) and heart rate (HR) were recorded continuously under baseline conditions and after the application of an air jet stressor. The stressor was applied three times with 10-min intervals. There were no significant differences in MABP and HR between groups under baseline conditions and immediately before the application of the three consecutive air jets. After the first stressor the IL-ANT group responded with a significantly lower increase in blood pressure than the control and IL-1B group. After the application of the two following air jets only the trend for an intergroup difference was present. The results of the present study provide further evidence that cytokines play an important role in the regulation of the circulatory system. The most important new finding is that the magnitude of the pressor response to the alarming stress is strongly influenced by IL-1 receptors in the brain.
Ufnal
Marcin
M
Department of Experimental and Clinical Physiology, Medical University of Warsaw, 00-927 Warsaw, Poland. marcinufnal@poczta.onet.pl
Sikora
Mariusz
M
Szczepanska-Sadowska
Ewa
E
D000704:Analysis of Variance; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004195:Disease Models, Animal; D006339:Heart Rate / Q000187:drug effects; D007276:Injections, Intraventricular / Q000379:methods; D053583:Interleukin-1beta / Q000494:pharmacology; D008297:Male; D010812:Physical Stimulation / Q000009:adverse effects; D051381:Rats; D011921:Rats, Inbred WKY; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013315:Stress, Psychological / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors
D053583:Interleukin-1beta; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins